SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000898430-02-001629
Filing Date
2002-04-29
Accepted
2002-04-26 18:11:05
Documents
5
Period of Report
2002-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.txt 10-Q 79649
3 COMPANY'S AMENDED EQUITY INCENTIVE PLAN dex1040.txt EX-10.40 37538
4 AGREEMENT BETWEEN AMGEN & DR. MILETICH dex1067.txt EX-10.67 22496
5 RESTRICTED STOCK PURCHASE AGREEMENT dex1068.txt EX-10.68 10142
6 FACTORS THAT MAY AFFECT AMGEN dex99.txt EX-99 22810
  Complete submission text file 0000898430-02-001629.txt   174740
Mailing Address ONE AMGEN CENTER DRIVE MAIL STOP 27-3-C THOUSAND OAKS CA 91320-1799
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 805-447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-12477 | Film No.: 02623640
SIC: 2836 Biological Products, (No Diagnostic Substances)